Back to Search
Start Over
Recent advances in understanding the phenotypes of osteoarthritis.
- Source :
-
F1000Research [F1000Res] 2019 Dec 12; Vol. 8. Date of Electronic Publication: 2019 Dec 12 (Print Publication: 2019). - Publication Year :
- 2019
-
Abstract
- Recent research in the field of osteoarthritis (OA) has focused on understanding the underlying molecular and clinical phenotypes of the disease. This narrative review article focuses on recent advances in our understanding of the phenotypes of OA and proposes that the disease represents a diversity of clinical phenotypes that are underpinned by a number of molecular mechanisms, which may be shared by several phenotypes and targeted more specifically for therapeutic purposes. The clinical phenotypes of OA supposedly have different underlying etiologies and pathogenic pathways and they progress at different rates. Large OA population cohorts consist of a majority of patients whose disease progresses slowly and a minority of individuals whose disease may progress faster. The ability to identify the people with relatively rapidly progressing OA can transform clinical trials and enhance their efficiency. The identification, characterization, and classification of molecular phenotypes of rapidly progressing OA, which represent patients who may benefit most from intervention, could potentially serve as the basis for precision medicine for this disabling condition. Imaging and biochemical markers (biomarkers) are important diagnostic and research tools that can assist with this challenge.<br />Competing Interests: Competing interests: Anne-Christine Bay-Jensen and Morten A. Karsdal are full-time employees and shareholders of Nordic Bioscience, a small–medium enterprise involved in biomarker identification, validation, and development. Ali Mobasheri has consulted for the following companies in the last three years: Abbvie, Aché Laboratórios Farmacêuticos S.A., AlphaSights, Galapagos, Guidepoint Global, Kolon TissueGene, Pfizer Consumer Health (PCH), Servier, Bioiberica S.A. and Science Branding Communications. No competing interests were disclosed.No competing interests were disclosed.<br /> (Copyright: © 2019 Mobasheri A et al.)
Details
- Language :
- English
- ISSN :
- 2046-1402
- Volume :
- 8
- Database :
- MEDLINE
- Journal :
- F1000Research
- Publication Type :
- Academic Journal
- Accession number :
- 31885861
- Full Text :
- https://doi.org/10.12688/f1000research.20575.1